Not available outside of the UK & Ireland.
Application
Amisulpride has been used as a dopamine receptor inhibitor to study its effects on diabetic bone abnormalities in mice.
Biochem/physiol Actions
Amisulpride is a substituted benzamide derivative. It has a higher affinity towards dopamine receptors in limbic structures than the striatal structures. Amisulpride has a therapeutic effect against schizophrenia.
Amisulpride is a highly selective D2/D3 dopamine receptor antagonist and atypical antipsychotic.
Features and Benefits
This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Packaging
10, 50 mg in glass bottle
This product has met the following criteria to qualify for the following awards: